Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24150MH1998PLC115539 Incorporated 29 June 1998 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company chemicals and materials
Data last updated
Revenue · FY 2025
₹58.98 Cr
▼ 5.00% YoY
EBITDA · FY 2025
*****
▼ 10.00% YoY
Net profit · FY 2025
*****
▼ 6.00% YoY
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹8.91 Cr
Issued & subscribed
Open charges
₹8 Cr
Satisfied ₹31.9 Cr
Company age
28 yrs
Est. 1998
Employees · EPFO
29
Latest available

About Globex Laboratories (R&D) Limited

Data last updated: 06 January 2026

Globex Laboratories (R&D) Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in dyes and pigments, a part of the broader chemicals and materials sector. Incorporated on 29 June 1998, the company has been in operation for over 28 years.

Registered with ROC Mumbai under CIN U24150MH1998PLC115539.

Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹8.91 Cr. Formerly known as Globex Laboratories (R&D) Private Limited and Rex-Tone Organic Industries Private Limited. It is led by directors including Shakun Harish Goswamy and Neerav Harish Goswamy.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 16 Yashodham Shopping Center Film City Road Goregaon (East), Mumbai, Maharashtra, India – 400063.

As per the financials filed for FY 2025, the company reported a revenue of ₹58.98 Cr, a decline of 5% compared to the previous year.

The company has a workforce of approximately 29 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹8 Cr and satisfied charges of ₹31.9 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Globex Laboratories (R&D) Limited
CIN U24150MH1998PLC115539
Registration Number 115539
Incorporation Date 29 June 1998
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Shakun Harish Goswamy Managing Director Neerav Harish Goswamy Director Harish Chunilal Goswamy Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    16 Yashodham Shopping Center Film City Road Goregaon (East), Mumbai, Maharashtra, India – 400063
  • Industry
    Chemicals and Materials, Dyes & Pigments, Colorants
Company report
Globex Laboratories (R&D) Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Globex Laboratories (R&D) Limited report

Financials, compliance, directors, charges, ownership and filings for Globex Laboratories (R&D) Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited has undergone 2 name changes throughout its history. The company was previously known as Globex Laboratories (R&D) Private Limited, and Rex-Tone Organic Industries Private Limited. The current legal name is Globex Laboratories (R&D) Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Globex Laboratories (R&D) Limited Current
Globex Laboratories (R&D) Private Limited Previous
Rex-Tone Organic Industries Private Limited Previous

CIN History of Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited has one previous CIN (Corporate Identification Number): U24150MH1998PTC115539. The current CIN is U24150MH1998PLC115539, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24150MH1998PLC115539 Current
U24150MH1998PTC115539 Previous

Business Activity of Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited is engaged in principal business activities including trade and manufacturing, with detailed activities including wholesale trading, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading *********
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited is audited by DESAI SAKSENA AND ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
DESAI SAKSENA AND ASSOCIATES blur-value blur-value blur-value

Board of Directors of Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Shakun Harish Goswamy
Also directs: Rex-Tone Industries Limited
Managing Director 29 Jun 1998 28 Years 0 Months Current
Neerav Harish Goswamy
Also directs: Rex-Tone Industries Limited, Hotel Polo Towers Limited
Director 29 Jun 1998 28 Years 0 Months Current
Harish Chunilal Goswamy
Also directs: Rex-Tone Industries Limited
Director 29 Jun 1998 28 Years 0 Months Current
View all directors

Financials of Globex Laboratories (R&D) Limited FY 2025 filings available

Globex Laboratories (R&D) Limited reported revenue of ₹58.98 Cr (down 5% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹58.98 Cr ▼ -5%
Profit
***** ▼ -6%
EBITDA
***** ▼ -10%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Globex Laboratories (R&D) Limited

As of FY 2023, Globex Laboratories (R&D) Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Globex Laboratories (R&D) Limited

Open charges
₹8 Cr
Satisfied charges
₹31.9 Cr
Breakdown by lending institutions
Others₹8.00 Cr
Latest charge details
DateLenderAmountStatus
23 Dec 2020 Others ₹8 Cr Open
24 Dec 2020 Others ₹50 Lakh Satisfied
06 Oct 2015 Others ₹9 Cr Satisfied
18 Apr 2013 Tata Capital Financial Services Limited ₹13 Cr Satisfied
11 Jan 2012 Others ₹9 Cr Satisfied

Total charge records: 6 View all charges

Employees and EPFO Compliance at Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited has a workforce of 29 employees as of Apr 08, 2024.

Employee count
29
Active EPFO establishments
1
Employee growth
11.54%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Globex Laboratories (R&D) Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Globex Laboratories (R&D) Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Globex Laboratories (R&D) Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Globex Laboratories (R&D) Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Globex Laboratories (R&D) Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Globex Laboratories (R&D) Limited

MSME Payment Delays by Globex Laboratories (R&D) Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Globex Laboratories (R&D) Limited

Subsidiaries & Group Companies of Globex Laboratories (R&D) Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Globex Laboratories (R&D) Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Globex Laboratories (R&D) Limited

MCA Filings & Documents of Globex Laboratories (R&D) Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Globex Laboratories (R&D) Limited

Activity
30 Sep 2025
Globex Laboratories (R&D) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Globex Laboratories (R&D) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
12 Mar 2024
A charge registered on 24 Dec 2020 via Charge ID 100396820 with Others was fully satisfied on 12 Mar 2024.
Charges
12 Mar 2021
A charge with Others of Rs. 0.50 Cr registered on 24 Dec 2020 with Charge ID 100396820 was modified on 12 Mar 2021.
Charges
12 Mar 2021
A charge with Others of Rs. 8.00 Cr registered on 23 Dec 2020 with Charge ID 100396821 was modified on 12 Mar 2021.
Charges
18 Feb 2021
A charge registered on 06 Oct 2015 via Charge ID 10595894 with Others was fully satisfied on 18 Feb 2021.

Frequently Asked Questions about Globex Laboratories (R&D) Limited

Globex Laboratories (R&D) Limited is an active public limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 29 June 1998 (28+ years old) and is registered under CIN U24150MH1998PLC115539. The company has 29 employees.

Globex Laboratories (R&D) Limited reported revenue of ₹58.98 Cr for FY 2025 (down 5.00% YoY).

The current directors of Globex Laboratories (R&D) Limited are:

The primary industry of Globex Laboratories (R&D) Limited is chemicals and materials. The company specifically operates in dyes and pigments. The company is currently active in this sector.

Globex Laboratories (R&D) Limited can be reached at the registered office: 16 Yashodham Shopping Center Film City Road Goregaon East, Mumbai, Maharashtra, India – 400063.

The authorised capital is ₹15 Cr, and the paid-up capital is ₹8.91 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available